Solute carrier family two member 1 (SLC2A1/GLUT1) was an important regulator of the glycolysis pathway and was found to have an increased expression in premalignant lesions and neoplasms of lung cancer patients due to tumors’ high demand of glucose (Ooi and Gomperts, 2015). This evidence concerns the gene SLC2A1 and lung carcinoma.